Polyrizon prepares for allergy blocker trial with strategic manufacturing partnership

Polyrizon Ltd., a biotech company known for its cutting-edge nasal hydrogel technology, has solidified its preparations for the anticipated 2025 allergy blocker trial by entering ... Read More